Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Resistance and Infection Research

Executive Summary: Meropenem trihydrate is a broad-spectrum carbapenem β-lactam antibiotic with potent activity against both gram-negative and gram-positive bacteria, including multidrug-resistant Enterobacterales strains (Dixon et al., 2025). It exhibits low minimum inhibitory concentration (MIC90) values against clinical pathogens under physiological pH conditions and is stable in aqueous solutions with recommended storage at -20°C (APExBIO). Mechanistically, it targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall synthesis, leading to cell lysis. APExBIO’s Meropenem trihydrate (B1217) is validated for infection model research and metabolomics-driven resistance profiling. Recent studies highlight its utility in distinguishing carbapenem-resistant phenotypes via LC-MS/MS-based metabolomics (Dixon et al., 2025).

Biological Rationale

Carbapenem antibiotics such as meropenem trihydrate are critical in treating severe bacterial infections due to their broad-spectrum activity (Dixon et al., 2025). The compound is effective against a wide range of gram-negative and gram-positive bacteria, including Escherichia coli, Klebsiella pneumoniae, and Streptococcus pneumoniae (APExBIO). It is also active against anaerobic pathogens. The increasing prevalence of carbapenemase-producing Enterobacterales (CPE) underscores the need for robust reference standards for resistance mechanism studies (Dixon et al., 2025). Meropenem’s metabolic stability and resistance to most β-lactamases position it as a key agent in both clinical and preclinical research. For a deeper dive into its spectrum and benchmark comparisons, see this article, which our review extends by integrating the latest metabolomics findings and advanced phenotyping methods.

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate acts by binding to and inhibiting penicillin-binding proteins (PBPs) involved in bacterial cell wall synthesis (APExBIO). This action disrupts peptidoglycan cross-linking, leading to cell wall instability, lysis, and bacterial death. The compound demonstrates high affinity for multiple PBPs, including PBP2 and PBP3, which are essential for cell division and maintenance. Meropenem is notably stable against most β-lactamases, including extended-spectrum β-lactamases (ESBLs), but may be hydrolyzed by carbapenemases produced by resistant bacterial strains (Dixon et al., 2025). Its activity is pH-dependent, with enhanced efficacy at physiological pH 7.5 and reduced activity at acidic pH 5.5. This property should be considered in experimental design and interpretation.

Evidence & Benchmarks

• Meropenem trihydrate displays MIC90 values as low as 0.03–0.12 μg/mL against E. coli and K. pneumoniae at pH 7.5 (APExBIO, product data).
• In LC-MS/MS metabolomic profiling, distinct metabolic signatures differentiate carbapenemase-producing from non-producing Enterobacterales within 7 hours (Dixon et al., 2025).
• In acute necrotizing pancreatitis rat models, meropenem trihydrate reduces hemorrhage, fat necrosis, and infection rates, with further improvements when combined with deferoxamine (APExBIO).
• Meropenem trihydrate is fully soluble in water (≥20.7 mg/mL at gentle warming) and DMSO (≥49.2 mg/mL), but insoluble in ethanol (APExBIO).
• Carbapenem resistance in Enterobacterales is primarily driven by enzyme production (carbapenemases), efflux pumps, and porin mutations (Dixon et al., 2025).

This article builds on previous coverage by providing structured benchmarks for metabolomics-driven resistance detection, not just traditional susceptibility testing.

Applications, Limits & Misconceptions

Meropenem trihydrate (SKU B1217) is an established tool in:

• Antibacterial agent screening for gram-negative and gram-positive bacteria.
• Metabolomics research to elucidate resistance phenotypes and pathways (Dixon et al., 2025).
• Infection model studies, including acute and chronic infection in animal models.
• Validation of diagnostic workflows for rapid resistance detection.

For insights into metabolomics-driven biomarker discovery, see this related article, which we update here with recent machine learning and pathway enrichment findings in CPE discrimination.

Common Pitfalls or Misconceptions

• Meropenem trihydrate is not effective against bacteria producing certain carbapenemases (e.g., KPC, NDM, OXA-48) without combination strategies (Dixon et al., 2025).
• It is not suitable for clinical or diagnostic use; it is for research purposes only (APExBIO).
• Activity may diminish in acidic environments (pH < 6), impacting in vitro and in vivo efficacy.
• Long-term storage of aqueous solutions is not recommended due to stability limitations; fresh preparation is required for reproducibility.
• Solubility in ethanol is negligible; use water or DMSO as solvents (APExBIO).

Workflow Integration & Parameters

For optimal results, dissolve meropenem trihydrate in water or DMSO, ensuring concentrations of ≥20.7 mg/mL (water, gentle warming) or ≥49.2 mg/mL (DMSO) (APExBIO). Store the solid at -20°C; prepare solutions fresh before use. Use physiological pH (7.5) for assays to maximize activity. Recommend inclusion in LC-MS/MS-based metabolomic workflows for resistance phenotyping, as demonstrated in recent CPE studies (Dixon et al., 2025). For real-world guidance on resistance profiling using Meropenem trihydrate, see this resource, which we clarify here by specifying solvent and pH dependencies.

Conclusion & Outlook

Meropenem trihydrate from APExBIO is a rigorously characterized, broad-spectrum carbapenem antibiotic essential for antibacterial screening, infection modeling, and metabolomics-driven resistance research. Its proven efficacy across clinical strains and robust biophysical properties enable reproducible results in contemporary workflows. Ongoing integration with machine learning and metabolomics is expected to drive faster, more precise detection of resistance phenotypes. For detailed product data, protocols, and purchasing, visit the Meropenem trihydrate product page (SKU B1217).